Is Carlsmed, Inc. (NASDAQ:CARL) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Carlsmed, Inc. at current levels.
Custom-printed spine implants designed by AI are quietly becoming the standard of care, and Carlsmed owns the only working playbook.
Where CARL is headed
Spine fusion is the last major orthopedic procedure still done with off-the-shelf hardware. A surgeon picks an implant from a tray of standard sizes, hammers it into a spine that was never standard, and hopes the geometry holds. Carlsmed's bet, which is starting to look obvious in hindsight, is that this entire workflow gets replaced by patient-specific implants designed from a CT scan, modeled in software, and 3D-printed in titanium before the surgeon scrubs in. Aprevo is the only FDA-cleared system doing this at commercial scale, and the clinical data keeps stacking in one direction: fewer revisions, better alignment, shorter hospital stays. CMS already granted aprevo a New Technology Add-on Payment, which means hospitals get paid extra to use it. That is the rarest unlock in medtech, and most investors still don't realize Carlsmed has it.
Read the full Compass Direction on CARL
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $11.29).
See the full CARL analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Carlsmed, Inc. (NASDAQ:CARL) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Carlsmed, Inc. at current levels. Custom-printed spine implants designed by AI are quietly becoming the standard of care, and Carlsmed owns the only working playbook.
What is CARL's Compass Score?
Carlsmed, Inc. scores 82/100 on Alexandria's Compass, placing it in the "True North" tier. Scores blend eight factors and update weekly.
What is the price target for CARL?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the CARL page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.